Syngene International, the contract research wing of Biocon Group, has acquired its first manufacturing facility in the US from Emergent Manufacturing Operations Baltimore. The pharma player has ...

Peter Bains, with over 30 years of global experience in biopharmaceuticals, was appointed group CEO of Biocon in September 2023. Holding a bachelor's degree in science from the University of Sheffield ...

February 1, 2023 India's Biocon sells 10% stake in Syngene via open market - filing Indian biopharma company Biocon sold a 9.96% stake in its unit and contract research firm Syngene International ...

Research services under Syngene were up 11% to Rs 944 crore. Also read: Q3 results today: Vedanta, Nestle among 134 companies to announce earnings on Friday Biocon on Thursday said its board has ...

The comments came from the Chairperson of Biocon in an exclusive chat with Business Insider. Syngene, a Biocon subsidiary, is involved in accelerating a bunch of initiatives to develop a vaccine ...

Syngene International had informed the exchanges late last night that Syngene USA has completed the acquisition of its first biologics site in the USA from Emergent Manufacturing Operations ...